Fedenia Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-115
Closed -$138K – 292
2026
Q2
$138K Buy
+115
New +$118K 0.03% 151
2026
Q1
– Sell
-305
Closed -$328K – 132
2025
Q4
$328K Sell
305
-37
-11% -$35.4K 0.13% 120
2025
Q3
$261K Buy
+342
New +$255K 0.1% 139
2025
Q2
– Sell
-338
Closed -$279K – 146
2025
Q1
$279K Buy
338
+212
+168% +$176K 0.18% 93
2024
Q4
$97.3K Buy
+126
New +$104K 0.06% 212

Other funds holding LLY

Fedenia Advisers's LLY Position: Q3 2026 in Review

Fedenia Advisers sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 115 shares — an estimated $138K sold.

Fedenia Advisers first reported a position in LLY in Q4 2024 and held it in 5 quarters. The position peaked at $328K in Q4 2025. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Fedenia Advisers reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
  • Fedenia Advisers sold 115 Eli Lilly shares in Q3 2026, an estimated $138K.
  • Fedenia Advisers first reported a position in Eli Lilly in Q4 2024 and held it in 5 quarters.
  • Fedenia Advisers's Eli Lilly position peaked at $328K in Q4 2025.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Fedenia Advisers's 13F filing for Q3 2026, filed 22 Oct 2026.